These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32464279)

  • 1. Mitochondrial migraine; a prevalence, impact and treatment efficacy cohort study.
    Tiehuis LH; Koene S; Saris CGJ; Janssen MCH
    Mitochondrion; 2020 Jul; 53():128-132. PubMed ID: 32464279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migraine in mitochondrial disorders: Prevalence and characteristics.
    Vollono C; Primiano G; Della Marca G; Losurdo A; Servidei S
    Cephalalgia; 2018 May; 38(6):1093-1106. PubMed ID: 28762753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Headache and migraine in mitochondrial disease and its impact on life-results from a cross-sectional, questionnaire-based study.
    Burow P; Meyer A; Naegel S; Watzke S; Zierz S; Kraya T
    Acta Neurol Belg; 2021 Oct; 121(5):1151-1156. PubMed ID: 33683636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Headache in Patients With Mitochondrial Disease: A Cross-Sectional Study.
    Kraya T; Deschauer M; Joshi PR; Zierz S; Gaul C
    Headache; 2018 Jan; 58(1):45-52. PubMed ID: 29139113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of migraine in persons with the 3243A>G mutation in mitochondrial DNA.
    Guo S; Esserlind AL; Andersson Z; Frederiksen AL; Olesen J; Vissing J; Ashina M
    Eur J Neurol; 2016 Jan; 23(1):175-81. PubMed ID: 26435168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstetric complications in carriers of the m.3243A>G mutation, a retrospective cohort study on maternal and fetal outcome.
    de Laat P; Fleuren LH; Bekker MN; Smeitink JA; Janssen MC
    Mitochondrion; 2015 Nov; 25():98-103. PubMed ID: 26455484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and impact of headache and migraine among Brazilian Tupiniquim natives.
    Domingues RB; Cezar PB; Schmidt Filho J; de Moraes Filho MN; Pinheiro MN; Marchiori JG; Brito F; Domingues SA
    Arq Neuropsiquiatr; 2009 Jun; 67(2B):413-5. PubMed ID: 19623436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence and characteristics of migraine in a population-based cohort: the GEM study.
    Launer LJ; Terwindt GM; Ferrari MD
    Neurology; 1999 Aug; 53(3):537-42. PubMed ID: 10449117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The UK migraine patient survey: quality of life and treatment.
    Dowson A; Jagger S
    Curr Med Res Opin; 1999; 15(4):241-53. PubMed ID: 10640257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migraine in 746 patients with multiple sclerosis.
    Fragoso YD; Adoni T; Alves-Leon SV; Apostolos-Pereira SL; Carneiro MAD; Chikota EM; Diniz DS; Eboni ACB; Gomes S; Gonçalves MVM; Goncalves RP; Inojosa JL; Junqueira TF; Machado SC; Malfetano FR; Mansur LF; Mendes MF; Muniz A; Nobrega Junior AW; Olival GSD; Parolin MF; Pimentel MLV; Rocha CF; Ruocco HH; Santos GC; Siquineli F; Soares JOD; Sousa NAC; Tauil CB; Winckler TCA
    Arq Neuropsiquiatr; 2019; 77(9):617-621. PubMed ID: 31553391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children.
    Uusimaa J; Moilanen JS; Vainionpää L; Tapanainen P; Lindholm P; Nuutinen M; Löppönen T; Mäki-Torkko E; Rantala H; Majamaa K
    Ann Neurol; 2007 Sep; 62(3):278-87. PubMed ID: 17823937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Migraine: Disentangling the angiopathy paradigm in m.3243A>G patients.
    Smeitink J; Koene S; Beyrath J; Saris C; Turnbull D; Janssen M
    JIMD Rep; 2019 Mar; 46(1):52-62. PubMed ID: 31240155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mitochondrial malady: stubborn seizures and atypical migraine.
    Vinjam M; Newby R; Davey R
    J R Coll Physicians Edinb; 2015; 45(4):281-3. PubMed ID: 27070891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with triptan use in episodic migraine: results from the American Migraine Prevalence and Prevention Study.
    Chu MK; Buse DC; Bigal ME; Serrano D; Lipton RB
    Headache; 2012 Feb; 52(2):213-23. PubMed ID: 22413150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migraine prevalence in adolescents aged 13-15: a student population-based study in Taiwan.
    Lu SR; Fuh JL; Juang KD; Wang SJ
    Cephalalgia; 2000 Jun; 20(5):479-85. PubMed ID: 11037745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Munjal S; Buse DC; Fanning KM; Bennett A; Reed ML
    Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migraine prevalence in male to female transsexuals on hormone therapy.
    Pringsheim T; Gooren L
    Neurology; 2004 Aug; 63(3):593-4. PubMed ID: 15304612
    [No Abstract]   [Full Text] [Related]  

  • 18. Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey.
    MacGregor EA; Brandes J; Eikermann A
    Headache; 2003 Jan; 43(1):19-26. PubMed ID: 12864754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomic & metabolic brain markers of the m.3243A>G mutation: A multi-parametric 7T MRI study.
    Haast RAM; Ivanov D; IJsselstein RJT; Sallevelt SCEH; Jansen JFA; Smeets HJM; de Coo IFM; Formisano E; Uludağ K
    Neuroimage Clin; 2018; 18():231-244. PubMed ID: 29868447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epilepsy in adults with mitochondrial disease: A cohort study.
    Whittaker RG; Devine HE; Gorman GS; Schaefer AM; Horvath R; Ng Y; Nesbitt V; Lax NZ; McFarland R; Cunningham MO; Taylor RW; Turnbull DM
    Ann Neurol; 2015 Dec; 78(6):949-57. PubMed ID: 26381753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.